top of page
Funding Partners

SUMMIT is funded by IMI, which is a public/private partnership between the European Commission (EC) and the European Federation of Pharmaceutical Industries and Associations (EFPIA). Each of the partners contributes with one billion EURO to the IMI budget for research grants. While the budget allocated by the EC will be exclusively awarded to beneficiaries from the public sector and to small and medium sized enterprises (SMEs), EFPIA partners will meet their budgetary obligations through in-kind contributions.


Project Partners​


SUMMIT brings together the scientific expertise and clinical resources of nineteen leading universities and research institutes, six pharmaceutical companies and one SME (small and medium sized enterprise).



To DISCOVER, DEVELOP and QUALIFY potential MARKERS that empower:

  • the identification of patients at high risk of diabetes complications

  • the monitoring of the complications' progression and patients‘ response to therapy 

To use the discovered markers as SURROGATE ENDPOINTS in clinical trials.

Thereby, SHORTEN the long lasting CLINICAL TRIALS to bring about EARLIER availability of NEW THERAPY to diabetic patients.

Related Sites

bottom of page